PRR36: A Potential Drug Target for Cancer and Other Diseases (G80164)

Target Name: PRR36

NCBI ID: G80164

PRR36

Other Name(s): PRR36_HUMAN | Proline-rich protein 36 | proline rich 36 | PRR36 variant 1 | Proline rich 36, transcript variant 1

PRR36: A Potential Drug Target for Cancer and Other Diseases

PRR36 is a protein that is expressed in human tissues and has been identified as a potential drug target in the treatment of various diseases, including cancer. The protein is derived from the heat shock protein (HSP) family and is composed of 36 amino acids.

HSPs are a family of proteins that are involved in the regulation of various cellular processes, including DNA replication, protein folding, and stress response. PRR36 is a member of the HSP family and is expressed in a variety of human tissues, including muscle, heart , brain, and cancer.

One of the key functions of PRR36 is its role in the regulation of DNA replication. PRR36 has been shown to play a role in the regulation of the DNA replication process in various cell types, including cancer cells. This protein has been shown to interact with the DNA replication complex, which includes the protein DNA polymerase (DNAPK), and the protein Telomere-associated protein TRF2.

In addition to its role in DNA replication, PRR36 has also been shown to play a role in the regulation of protein folding. PRR36 has been shown to interact with the protein FUS1, which is involved in the regulation of protein folding in the cell. The interaction between PRR36 and FUS1 suggests that PRR36 may be a potential drug target for diseases that are characterized by the misfolding of proteins.

PRR36 has also been shown to be involved in the regulation of stress response. PRR36 has been shown to interact with the protein heat shock protein (HSP70), which is involved in the regulation of stress response in the cell. This interaction between PRR36 and HSP70 suggests that PRR36 may be a potential drug target for diseases that are characterized by the regulation of stress response.

In conclusion, PRR36 is a protein that has been shown to play a number of important roles in the regulation of various cellular processes, including DNA replication, protein folding, and stress response. While more research is needed, PRR36 is a potential drug target for a variety of diseases, including cancer.

Protein Name: Proline Rich 36

The "PRR36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRR36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets